Navigation Links
LABS, Inc. Among Colorado's Top Private Companies
Date:11/10/2011

CENTENNIAL, Colo., Nov. 10, 2011 /PRNewswire/ -- LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, today announced that it ranked #52 among Colorado's top private companies, as judged by the annual ColoradoBiz Top 250 Private Companies list.

The Top 250 Private Companies list is an annual ranking based on self-reported revenues of Colorado companies. Centennial-based LABS provides an intimate customer service experience, which results in personalized laboratory solutions for clients in any stage of the product development lifecycle: donor eligibility, R&D, processing and validation and final lot release.  LABS has an established and trusted record of personalized service, compliance and integrity. The Company serves a variety of industries that are focused on advancing and understanding biologic-based products.

"Our mission is to provide quality laboratory services for outstanding patient outcomes, and our commitment to this fundamental philosophy has propelled our business forward," said Elizabeth Hearty, Chief Executive Officer of LABS, Inc. "We are honored to be recognized among Colorado's top private companies, and we look forward to continuing to grow in this community."

"It's encouraging for all businesses out there to see companies in our annual Top 250 list like LABS, Inc. growing despite the sputtering economy," said ColoradoBiz Managing Editor Mike Taylor. "These are firms we expect to lead the way to an economic turnaround."    

About LABS, Inc.

LABS, Inc. is a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices. LABS provides an intimate customer service experience, which results in personalized laboratory solutions for clients in any stage of the product development lifecycle: donor eligibility, R&D, processing and validation and final lot release.  

LABS has an established and trusted record of personalized service, compliance and integrity. The Company serves a variety of industries that are focused on advancing and understanding biologic-based products.

The company is headquartered in Centennial, CO with satellite facilities in St. Louis, MO and Philadelphia, PA. LABS receives sample shipments from across the globe and performs testing for 10 nations outside of the U.S.: Australia (TGA certified), Singapore, Korea, Canada, Mexico, Brazil, Ecuador, England, Germany and Italy.  To learn more, visit www.labs-inc.org.


'/>"/>
SOURCE LABS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
2. LABS, Inc. Promotes Chad Ronholdt to VP of Strategic Development
3. GeoVax Labs, Inc. Announces First Quarter Financial Results
4. Scarguard Labs, LLC Gains Approval to Sell Scarguard in Canada
5. SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings
6. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
7. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
8. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
9. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
10. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
11. GeoVax Labs, Inc. Provides Clinical Studies Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology:
(Date:8/23/2017)... public,s help is being enlisted in what,s thought to be the biggest ... human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date ... project's goal is to help advance scientific knowledge of the role of ... The ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
Breaking Biology News(10 mins):